These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 1698740)
21. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection. Koevary SB; Beaudry K Ocul Immunol Inflamm; 2000 Mar; 8(1):39-47. PubMed ID: 10806433 [TBL] [Abstract][Full Text] [Related]
22. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival. Niederkorn JY; Mayhew E; Mellon J; Hegde S Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491 [TBL] [Abstract][Full Text] [Related]
23. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen. Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347 [TBL] [Abstract][Full Text] [Related]
24. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. Niederkorn JY; Streilein JW J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396 [TBL] [Abstract][Full Text] [Related]
25. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. Geiger K; Sarvetnick N J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729 [TBL] [Abstract][Full Text] [Related]
26. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors. Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486 [TBL] [Abstract][Full Text] [Related]
27. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation. Ishioka M; Okamoto S; Streilein JW; Jiang LQ Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279 [TBL] [Abstract][Full Text] [Related]
28. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438 [TBL] [Abstract][Full Text] [Related]
29. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. Hara Y; Okamoto S; Rouse B; Streilein JW J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216 [TBL] [Abstract][Full Text] [Related]
30. Analysis of immune deviation elicited by antigens injected into the subretinal space. Wenkel H; Streilein JW Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405 [TBL] [Abstract][Full Text] [Related]
31. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens. Williamson JS; Streilein JW Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942 [TBL] [Abstract][Full Text] [Related]
32. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens. Benson JL; Niederkorn JY Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974 [TBL] [Abstract][Full Text] [Related]
33. Anterior chamber-associated immune deviation induced by soluble antigens. Mizuno K; Clark AF; Streilein JW Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026 [TBL] [Abstract][Full Text] [Related]
34. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells. Wang Y; O'Rourke J; Cone RE Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893 [TBL] [Abstract][Full Text] [Related]
35. Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation. Williamson JS; Streilein JW Transplantation; 1989 Mar; 47(3):519-24. PubMed ID: 2493700 [TBL] [Abstract][Full Text] [Related]
36. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Ferguson TA; Herndon JM Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727 [TBL] [Abstract][Full Text] [Related]
38. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines. Chen PW; Ksander BR Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019 [TBL] [Abstract][Full Text] [Related]
39. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty. Miyazaki D; Inoue Y; Yao YF; Okada AA; Shimomura Y; Hayashi K; Tano Y; Ohashi Y Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2590-7. PubMed ID: 10509654 [TBL] [Abstract][Full Text] [Related]
40. Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation. Williamson JS; DiMarco S; Streilein JW Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1527-32. PubMed ID: 3623837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]